Goldman Sachs

Goldman Sachs’s Celularity Inc CELUW Stock Holding History

Goldman Sachs’s Portfolio CELUW Stock Details CELUW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-91,600	Closed	-$264K	–	6102
2020 Q4	$264K	Buy	+91,600	New	+$172K	﹤0.01%	4947

Other funds holding CELUW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Goldman Sachs's CELUW Position: Q1 2021 in Review

Goldman Sachs sold out of Celularity Inc (CELUW) in Q1 2021, closing a stake of 91,600 shares — an estimated $264K sold.

Goldman Sachs first reported a position in CELUW in Q4 2020 and held it in 1 quarter. The position peaked at $264K in Q4 2020. 23 funds tracked by Wall St. Rank hold CELUW as of Q1 2021.

Goldman Sachs reported no remaining Celularity Inc position as of Q1 2021 after selling out during the quarter.
Goldman Sachs sold 91,600 Celularity Inc shares in Q1 2021, an estimated $264K.
Goldman Sachs first reported a position in Celularity Inc in Q4 2020 and held it in 1 quarter.
Goldman Sachs's Celularity Inc position peaked at $264K in Q4 2020.
23 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2021.

Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.